PROLENSA (bromfenac ophthalmic solution) 0.07% is a once daily ophthalmic nonsteroidal anti-inflammatory drug (NSAID) for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.1
PROLENSA 1.6 mL Bottle NDC# 24208-602-01
PROLENSA 3 mL Bottle NDC 24208-602-03
Indications and Usage
PROLENSA (bromfenac ophthalmic solution) 0.07% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
Dosage and Administration
Instill one drop into the affected eye once daily beginning 1 day prior to surgery, continued on the day of surgery and through the first 14 days post-surgery.
Warnings and Precautions
- Sulfite allergic reactions
- Slow or delayed healing
- Potential for cross-sensitivity
- Increase bleeding of ocular tissues
- Corneal effects including keratitis
- Contact lens wear
The most commonly reported adverse reactions in 3%-8% of patients were anterior chamber inflammation, foreign body sensation, eye pain, photophobia, and blurred vision.
Please click here(53.5 KB, PDF) to view the Prolensa full Prescribing Information.